Literature DB >> 35253008

Helicobacter pylori eradication therapy is not associated with increased risk of cardiovascular mortality, based on a national cohort study.

Shailja C Shah1,2, Sunish Shah3,4, Alese E Halvorson5, Adriana Hung6,7, Robert A Greevy5,6, Christianne L Roumie6,8,9.   

Abstract

Entities:  

Keywords:  antibiotics; arrythmia; drug safety; gastroenterology; kidney disease; sudden cardiac death

Year:  2022        PMID： 35253008      PMCID： PMC8889490          DOI： 10.1016/j.gastha.2021.10.003

Source DB:  PubMed          Journal:  Gastro Hep Adv        ISSN： 2772-5723


× No keyword cloud information.
  8 in total

1.  ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Authors:  William D Chey; Grigorios I Leontiadis; Colin W Howden; Steven F Moss
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

2.  Clarithromycin use and risk of death in patients with ischemic heart disease.

Authors:  Søren Skøtt Andersen; Morten Lock Hansen; Mette Lykke Norgaard; Fredrik Folke; Emil Loldrup Fosbøl; Steen Z Abildstrøm; Jakob Raunsø; Mette Madsen; Lars Køber; Gunnar H Gislason; Christian Torp-Pedersen
Journal:  Cardiology       Date:  2010-06-05       Impact factor: 1.869

Review 3.  Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.

Authors:  David Zeltser; Dan Justo; Amir Halkin; Vitaly Prokhorov; Karin Heller; Sami Viskin
Journal:  Medicine (Baltimore)       Date:  2003-07       Impact factor: 1.889

4.  Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis.

Authors:  Einat Gorelik; Reem Masarwa; Amichai Perlman; Victoria Rotshild; Momen Abbasi; Mordechai Muszkat; Ilan Matok
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

5.  Association between Helicobacter pylori eradication and the risk of coronary heart diseases.

Authors:  Jiunn-Wei Wang; Kuo-Lun Tseng; Chien-Ning Hsu; Chih-Ming Liang; Wei-Chen Tai; Ming-Kun Ku; Tsung-Hsing Hung; Lan-Ting Yuan; Seng-Howe Nguang; Shih-Cheng Yang; Cheng-Kun Wu; Chien-Hua Chiu; Kai-Lung Tsai; Meng-Wei Chang; Chih-Fang Huang; Pin-I Hsu; Deng-Chyang Wu; Seng-Kee Chuah
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

6.  Effect of Helicobacter pylori Treatment on Long-term Mortality in Patients with Hypertension.

Authors:  Young-Il Kim; Young Ae Kim; Jang Won Lee; Hak Jin Kim; Su-Hyun Kim; Sang Gyun Kim; Jin Il Kim; Jae J Kim; Il Ju Choi
Journal:  Gut Liver       Date:  2019-07-24       Impact factor: 4.519

7.  Cardiovascular outcomes associated with use of clarithromycin: population based study.

Authors:  Angel Y S Wong; Adrian Root; Ian J Douglas; Celine S L Chui; Esther W Chan; Yonas Ghebremichael-Weldeselassie; Chung-Wah Siu; Liam Smeeth; Ian C K Wong
Journal:  BMJ       Date:  2016-01-14

8.  Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs.

Authors:  Adrian A Root; Angel Y S Wong; Yonas Ghebremichael-Weldeselassie; Liam Smeeth; Krishnan Bhaskaran; Stephen J W Evans; Ruth Brauer; Ian Chi Kei Wong; Vidya Navaratnam; Ian Douglas
Journal:  Br J Clin Pharmacol       Date:  2016-06-08       Impact factor: 4.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.